Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, Carmen Blanco Aparicio, Juan F. Martínez Leal, Paloma de La Cueva, Ma Elena Rodriguez, Beatriz Herreros, Daniel Martin-Perez, Maria I. Longo, Marta Herrera, Miguel Á. Piris, Pablo L Ortiz-Romero. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. Haematologica 2010;95(4):613-621; https://doi.org/10.3324/haematol.2009.013870.